Skip to main content
logo
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
31.16
+0.96 (3.18%)
Aug 21, 2026, 4:08 PM HKT

HKG:3378 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Market Capitalization
4,2452,177--
Market Cap Growth
----
Enterprise Value
3,6372,106--
Last Close Price
31.1615.98--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
PS Ratio
41459.4721262.04--
PB Ratio
5.102.62--
P/TBV Ratio
5.472.81--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
-20565.97--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.080.080.060.05
Net Debt / Equity Ratio
-0.80-0.80-0.75-0.59
Net Debt / EBITDA Ratio
4.194.191.393.11
Net Debt / FCF Ratio
5.725.721.463.37
Asset Turnover
000.00-
Quick Ratio
6.866.860.883.25
Current Ratio
7.277.271.234.75
Return on Equity (ROE)
-27.27%-27.27%-43.61%-
Return on Assets (ROA)
-12.63%-12.63%-13.64%-
Return on Capital Employed (ROCE)
-17.30%-17.30%-39.00%-11.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-3.43%-6.70%--
FCF Yield
-2.73%-5.33%--
Buyback Yield / Dilution
--0.34%-1516.00%-